Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 1 July 1988:
Vol. 241. no. 4861, pp. 79 - 81
DOI: 10.1126/science.3388020

Articles

Science, Vol 241, Issue 4861, 79-81
Copyright © 1988 by American Association for the Advancement of Science


articles

Induction of gene amplification by arsenic

TC Lee, N Tanaka, PW Lamb, TM Gilmer, and JC Barrett

Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.

Arsenic is a well-established carcinogen in humans, but there is little evidence for its carcinogenicity in animals and it is inactive as an initiator or tumor promoter in two-stage models of carcinogenicity in mice. Two arsenic salts (sodium arsenite and sodium arsenate) induced a high frequency of methotrexate-resistant 3T6 cells, which were shown to have amplified copies of the dihydrofolate reductase gene. The ability of arsenic to induce gene amplification may relate to its carcinogenic effects in humans since amplification of oncogenes is observed in many human tumors. The inability of arsenic to induce gene mutations may relate to the negative results of arsenic in long-term animal studies and suggests that these experiments may not detect some environmental agents that act late in the carcinogenic process in humans.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh..
M. V Gamble, X. Liu, H. Ahsan, J R. Pilsner, V. Ilievski, V. Slavkovich, F. Parvez, Y. Chen, D. Levy, P. Factor-Litvak, et al. (2006)
Am. J. Clinical Nutrition 84, 1093-1101
   Abstract »    Full Text »    PDF »
Cyclooxygenase-2 Induction by Arsenite Is through a Nuclear Factor of Activated T-cell-dependent Pathway and Plays an Antiapoptotic Role in Beas-2B Cells.
J. Ding, J. Li, C. Xue, K. Wu, W. Ouyang, D. Zhang, Y. Yan, and C. Huang (2006)
J. Biol. Chem. 281, 24405-24413
   Abstract »    Full Text »    PDF »
Invited Reviews: Carcinogenic and Systemic Health Effects Associated with Arsenic Exposure--A Critical Review.
P. B. Tchounwou, A. K. Patlolla, and J. A. Centeno (2003)
Toxicol Pathol 31, 575-588
   Abstract »    PDF »
Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice.
E. I. Salim, H. Wanibuchi, K. Morimura, M. Wei, M. Mitsuhashi, K. Yoshida, G. Endo, and S. Fukushima (2003)
Carcinogenesis 24, 335-342
   Abstract »    Full Text »    PDF »
Arsenic-Related Chromosomal Alterations in Bladder Cancer.
L. E. Moore, A. H. Smith, C. Eng, D. Kalman, S. DeVries, V. Bhargava, K. Chew, D. Moore II, C. Ferreccio, O. A. Rey, et al. (2002)
J Natl Cancer Inst 94, 1688-1696
   Abstract »    Full Text »    PDF »
Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
M. Wei, H. Wanibuchi, K. Morimura, S. Iwai, K. Yoshida, G. Endo, D. Nakae, and S. Fukushima (2002)
Carcinogenesis 23, 1387-1397
   Abstract »    Full Text »    PDF »
Backing into Cancer: Effects of Arsenic on Cell Differentiation.
K. Salnikow and M. D. Cohen (2002)
Toxicol. Sci. 65, 161-163
   Abstract »    Full Text »    PDF »
Suppression of gene amplification and chromosomal DNA integration by the DNA mismatch repair system.
C.-T. Lin, Y. L. Lyu, H. Xiao, W.-H. Lin, and J. Whang-Peng (2001)
Nucleic Acids Res. 29, 3304-3310
   Abstract »    Full Text »    PDF »
Quantitative Relationship between Arsenic Exposure and AP-1 Activity in Mouse Urinary Bladder Epithelium.
P. P. Simeonova, S. Wang, M. L. Kashon, C. Kommineni, E. Crecelius, and M. I. Luster (2001)
Toxicol. Sci. 60, 279-284
   Abstract »    Full Text »    PDF »
Arsenite Induces p53 Accumulation through an ATM-dependent Pathway in Human Fibroblasts.
L.-H. Yih and T.-C. Lee (2000)
Cancer Res. 60, 6346-6352
   Abstract »    Full Text »
Effects of Arsenite on Estrogen Receptor-{alpha} Expression and Activity in MCF-7 Breast Cancer Cells.
A. Stoica, E. Pentecost, and M. B. Martin (2000)
Endocrinology 141, 3595-3602
   Abstract »    Full Text »    PDF »
Is the Human Carcinogen Arsenic Carcinogenic to Laboratory Animals?.
J. Huff, P. Chan, and A. Nyska (2000)
Toxicol. Sci. 55, 17-23
   Full Text »    PDF »
Expression cloning for arsenite-resistance resulted in isolation of tumor-suppressor fau cDNA: possible involvement of the ubiquitin system in arsenic carcinogenesis.
T. G. Rossman and Z. Wang (1999)
Carcinogenesis 20, 311-316
   Abstract »    Full Text »    PDF »
Arsenic Enhancement of Skin Neoplasia by Chronic Stimulation of Growth Factors.
D. R. Germolec, J. Spalding, H.-S. Yu, G. S. Chen, P. P. Simeonova, M. C. Humble, A. Bruccoleri, G. A. Boorman, J. F. Foley, T. Yoshida, et al. (1998)
Am. J. Pathol. 153, 1775-1785
   Abstract »    Full Text »    PDF »
Mutagenicity of arsenic in mammalian cells: Role of reactive oxygen species.
T. K. Hei, S. X. Liu, and C. Waldren (1998)
PNAS 95, 8103-8107
   Abstract »    Full Text »    PDF »
Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression.
C. Q. Zhao, M. R. Young, B. A. Diwan, T. P. Coogan, and M. P. Waalkes (1997)
PNAS 94, 10907-10912
   Abstract »    Full Text »    PDF »
Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity.
S. X. Liu, M. Athar, I. Lippai, C. Waldren, and T. K. Hei (2001)
PNAS 98, 1643-1648
   Abstract »    Full Text »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)